Thrafford is dedicated to revolutionizing cancer treatment through the development and implementation of accessible & affordable Chimeric Antigen Receptor T-cell (CAR-T) therapy in India and beyond.
With cutting-edge research and a team of talented scientists, we strive to develop innovative solutions to some of the world's most pressing problems. Our mission is to make a positive impact on society through our work, and we are committed to excellence in all that we do.
Stay up-to-date with the latest developments at Thrafford Lifescience. From groundbreaking research to new product releases, our news section has everything you need to know about our company.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.